• Profile
Close

Advanced glycation end products are associated with inflammation and endothelial dysfunction in HIV

Journal of Acquired Immune Deficiency Syndromes May 23, 2019

El Kamari V, et al. - Researchers conducted a cross-sectional study involving 90 individuals (68 HIV+ and 22 healthy controls matched by age and sex) comparing HIV-infected patients and uninfected controls regarding levels of advanced glycation end products (AGEs). In addition, they assessed the relationship between AGEs, HIV, inflammation, and endothelial dysfunction. Using 3 different modalities, they assessed AGE levels: free AGEs were measured in the serum, skin autofluorescence (AF) was determined with a noninvasive reader, and dietary AGEs were estimated using 24-hour dietary recalls. HIV-infected participants vs uninfected controls had significantly higher skin AF and serum AGEs. The HIV-infected group but not controls showed a significant association of skin AF and circulating AGEs with inflammatory and oxidative markers, and with markers of endothelial dysfunction. Intrinsic production of AGE is suggested in HIV-infected individuals. As per findings, AGEs seems to have potential implications in chronic inflammation and endothelial dysfunction in HIV. This suggests a new potential target for HIV-associated heightened inflammation and cardiovascular risk.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay